pyrroles has been researched along with curcumin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 9 (75.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L; Renier, G; Sawamura, T | 1 |
| Chandra, N; Mateen, AA; Naidu, MU; Raju, YS; Usharani, P | 1 |
| Saif, MW; Strimpakos, AS; Syrigos, KN | 1 |
| Chen, CR; Kodra, JT; Liu, X; Yu, R | 1 |
| Banerjee, P; Begum, S; Castellanos, MR; Debata, PR; Genzer, O; Kleiner, MJ; Mata, A | 1 |
| Camarillo, C; Jiang, L; Li, Y; Meng, J; Xu, C; Yao, Y; Zhang, Y | 1 |
| Alonso, V; Asensio, E; Camps, J; Castells, A; Codony-Servat, J; Cuatrecasas, M; Escudero, P; Feliu, J; Fernández-Martos, C; Gaba, L; Gallego, J; García-Albéniz, X; Horndler, C; Jares, P; Marín-Aguilera, M; Martín-Richard, M; Martínez-Balibrea, E; Martínez-Cardús, A; Maurel, J; Méndez, JC; Méndez, M; Montironi, C; Prat, A; Reig, O; Rojo, F; Rosell, R; Rubini, M; Salud, A; Victoria, I | 1 |
| Georgieva, A; Manolova, N; Markova, N; Rashkov, I; Spasova, M; Toshkova, R; Tsekova, P | 1 |
| Bansal, A; Bhardwaj, V; Chattopadhyay, P; Nehra, S; Saraswat, D | 1 |
| Cudzich-Madry, A; Fragiadaki, M; Huang, Z; Patera, F | 1 |
| Arndtsen, BA; Erguven, H; Gran, ER; Hanna, R; Kakkar, A; Liang, T; Maysinger, D; Moquin, A | 1 |
| Cui, X; Jia, F; Li, Y; Pan, Z; Wang, X; Wu, Y | 1 |
1 trial(s) available for pyrroles and curcumin
| Article | Year |
|---|---|
Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Atorvastatin; Biomarkers; Blood Glucose; Cholesterol; Curcumin; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Female; Glycated Hemoglobin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Oxidative Stress; Pyrroles; Triglycerides | 2008 |
11 other study(ies) available for pyrroles and curcumin
| Article | Year |
|---|---|
Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation.
Topics: Acetylcysteine; Adult; Aged; Anti-Infective Agents; Antioxidants; Arteriosclerosis; Cells, Cultured; Curcumin; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Flavonoids; Foam Cells; Gene Expression Regulation; Glucose; Glycation End Products, Advanced; Humans; Hyperglycemia; Macrophages; Male; MAP Kinase Signaling System; Mesylates; Middle Aged; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; NF-kappa B; Nitriles; Phosphorylation; Protein Kinase C; Protein Kinase C beta; Protein Processing, Post-Translational; Pyrroles; Receptors, LDL; RNA, Messenger; Signal Transduction; Sulfones; Transcription Factor AP-1; Tumor Necrosis Factor-alpha | 2004 |
Translational research in pancreatic cancer. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Survival; Curcumin; Cyclooxygenase 2 Inhibitors; Epitopes; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mucins; Pancreatic Neoplasms; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinase Inhibitors; Pyrroles; Radiation-Sensitizing Agents; Sulfonamides; Translational Research, Biomedical; Xenograft Model Antitumor Assays | 2011 |
Rescue of a pathogenic mutant human glucagon receptor by pharmacological chaperones.
Topics: Alanine; Asparagine; Cell Membrane; Curcumin; Cyclic AMP; Drug Design; Glucagon; Green Fluorescent Proteins; HEK293 Cells; Humans; Molecular Chaperones; Mutation; Pancreatic Neoplasms; Protein Transport; Pyridines; Pyrroles; Receptors, Glucagon; Serine; Thapsigargin | 2012 |
Curcumin potentiates the ability of sunitinib to eliminate the VHL-lacking renal cancer cells 786-O: rapid inhibition of Rb phosphorylation as a preamble to cyclin D1 inhibition.
Topics: Antineoplastic Agents; CDC2 Protein Kinase; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Curcumin; Cyclin D1; Cyclin-Dependent Kinase 4; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Indoles; Inhibitory Concentration 50; Niacinamide; Phenylurea Compounds; Phosphorylation; Pyrroles; Retinoblastoma Protein; Signal Transduction; Sorafenib; Sunitinib | 2013 |
The anti-tumor histone deacetylase inhibitor SAHA and the natural flavonoid curcumin exhibit synergistic neuroprotection against amyloid-beta toxicity.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Cell Survival; CREB-Binding Protein; Curcumin; Disease Progression; Drug Synergism; E1A-Associated p300 Protein; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Histone Deacetylase Inhibitors; Neurons; Neuroprotective Agents; Nylons; Oxidative Stress; PC12 Cells; Pyrroles; Rats | 2014 |
Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Cell Nucleus; Cell Survival; Cetuximab; Colorectal Neoplasms; Curcumin; Dasatinib; Drug Resistance, Neoplasm; Fatty Acids, Unsaturated; Female; Fluorouracil; Gene Silencing; HCT116 Cells; HT29 Cells; Humans; Leucovorin; Male; Middle Aged; Molecular Chaperones; Molecular Targeted Therapy; Niacinamide; Organoplatinum Compounds; Oxaliplatin; Panitumumab; Phenylurea Compounds; Protein Inhibitors of Activated STAT; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); Pyrimidines; Pyrroles; Receptor, IGF Type 1; Signal Transduction; Sorafenib | 2017 |
Еlectrospun сellulose acetate membranes decorated with curcumin-PVP particles: preparation, antibacterial and antitumor activities.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bandages; Biocompatible Materials; Cellulose; Curcumin; Escherichia coli; HeLa Cells; Humans; Materials Testing; Microscopy, Electron, Scanning; Pyrroles; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; X-Ray Diffraction | 2017 |
Nanocurcumin-pyrroloquinoline formulation prevents hypertrophy-induced pathological damage by relieving mitochondrial stress in cardiomyocytes under hypoxic conditions.
Topics: Animals; Cell Survival; Cells, Cultured; Curcumin; Hypertrophy; Hypertrophy, Right Ventricular; Hypoxia; Male; Mitochondria; Myocytes, Cardiac; Pyrroles; Quinolines; Rats; Rats, Sprague-Dawley | 2017 |
Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.
Topics: Animals; Cell Line; Cell Proliferation; Curcumin; Disease Models, Animal; Epithelial Cells; Humans; Janus Kinase 2; Kidney; Mice; Phosphorylation; Piperidines; Polycystic Kidney, Autosomal Dominant; Pyrimidines; Pyrroles; TRPP Cation Channels; Up-Regulation | 2019 |
PEG-conjugated pyrrole-based polymers: one-pot multicomponent synthesis and self-assembly into soft nanoparticles for drug delivery.
Topics: Cell Line, Tumor; Curcumin; Drug Carriers; Fluorescence Resonance Energy Transfer; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Microscopy, Electron, Transmission; Nanoparticles; Polyethylene Glycols; Polymers; Pyrroles; Spectrophotometry, Ultraviolet | 2019 |
Boosting nutrient starvation-dominated cancer therapy through curcumin-augmented mitochondrial Ca
Topics: Apoptosis; Autophagy; Cell Line, Tumor; Curcumin; Glucose; Humans; Indoles; Neoplasms; Nutrients; Pyrroles; Starvation | 2022 |